US Archives - Page 5 of 97 - European Medical Journal

Switching Early to Camizestrant May Delay Progression: ASCO 2025

Switching to camizestrant upon detection of an ESR1 mutation, before clinical disease progression, may extend progression-free survival (PFS) for patients with hormone receptor (HR)-positive, HER2-negative advanced breast cancer, according to results from the Phase III SERENA-6 trial.

Mood Symptoms Linked to Poorer Progressive Supranuclear Palsy Outcomes

Depression and anxiety, not motor decline, are the strongest predictors of quality of life in patients with progressive supranuclear palsy (PSP), according to a new study that underscores the pressing need for comprehensive symptom management beyond traditional motor assessments.

Why Female Shift Workers Face Higher Asthma Risk

Female night shift workers may face a significantly increased risk of developing asthma, according to a new study that analyzed data from more than 280,000 participants.

The Rise of Onco-Rheumatology: A New Era Begins

As cancer therapies evolve and autoimmune diseases become more prevalent, the intersection of oncology and rheumatology, onco-rheumatology, is emerging as a critical field demanding transdisciplinary care.

Ceftazidime-Avibactam Resistance Emerges During Therapy

In a concerning development for infectious disease management, researchers have identified the emergence of ceftazidime-avibactam resistance in Klebsiella pneumoniae during the course of therapy, driven by novel mutations in KPC enzymes.

JAK Inhibitor Acne Common in Middle-Aged IBD

Acne has emerged as a frequent and clinically relevant side effect in patients with inflammatory bowel disease (IBD) treated with JAK inhibitors, according to the largest international retrospective cohort study to date on this adverse event.

ATS 2025 Interview: Raed Dweik

As a physician-scientist, studying the pulmonary circulation has given me the opportunity to align my clinical practice in…

ATS 2025 Interview: Jesse Roman

In my view, the best patient care enterprises are those that efficiently integrate research and education. In following the Flexnerian…

Diagnostic Gaps Revealed in Small Fiber Neuropathy

Clinical evaluation of small fiber neuropathy (SFN) remains inconsistent across neurology subspecialties, with survey data revealing wide variation in diagnostic practices, even when faced with common patient scenarios.

PAV+ Fails to Shorten Ventilation Time Compared to PSV

A new multicenter trial has found that proportional-assist ventilation with load-adjustable gain factors (PAV+) does not reduce the time to successful liberation from mechanical ventilation compared to conventional pressure-support ventilation (PSV) in critically ill adults.